XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 4 - Debt
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Debt Disclosure [Text Block]
Note
4
--
Debt
           
 
   
September 30
   
December 31
 
   
2017
   
2016
 
                 
Term loan
  $
2,626,661
    $
2,843,301
 
Notes payable
   
-
     
64,136
 
     
2,626,661
     
2,907,437
 
Less current portion
   
2,626,661
     
389,096
 
Total long-term debt
  $
-
    $
2,518,341
 
 
 
Effective
September 30, 2015,
the Company entered into a series of lending agreements with a new primary lender which include agreements for a
$3.25
million term loan and a
$3.5
million revolving credit facility.
  These lending agreements replaced similar borrowings under agreements with the Company’s former primary lender.
               
 
The
$3.25
million term loan is for a period of
three
years and requires monthly term loan payments, under a
ten
-year amortization, consisting of principal of
$27,080
plus interest with a balloon payment for the outstanding balance due and payable on
September 30, 2018.
  Accordingly, the outstanding term loan balance is presented as a current liability in the
September 30, 2017
consolidated balance sheet.  The term loan's interest rate is based on the
30
-day LIBOR plus
2.25%
and was
3.48%
at
September 30, 2017.
               
 
The
$3.5
million revolving line of credit agreement, originally dated
September 30, 2015,
accrues interest at a floating interest rate based on the
30
-day LIBOR plus
2.25%
and had an original term of
one
year.
  Effective
September 30, 2016,
the revolving line of credit agreement was extended under similar terms to
April 30, 2018. 
As of
September 30, 2017,
there were
no
outstanding borrowings on the revolving line of credit.  In
October 2017,
the Company borrowed
$500,000
under the revolving line of credit.
               
 
Borrowings under the lending agreements are secured by all tangible and intangible assets of the Company, a whole life insurance policy on the life of the Company's Chief Executive Officer, and by a mortgage on the real estate of the Company's headquarters.
               
 
The lending agreements include quarterly financial covenants requiring the Company to maintain net tangible worth of
not
less than
$9.5
million, and
  i) a cumulative minimum EBITDA requirement of
$600,000
and
$800,000
for the fiscal periods ending
September 30, 2017
and
December 31, 2017,
respectively; and  ii) a minimum EBITDA of
$200,000
for the quarter ended
March 31, 2018.
               
 
As defined, EBITDA equals the Company's consolidated net income for such period, before interest expense, income tax expense, depreciation and amortization, and management fees, and further adjusted to exclude any gain or loss on the sale of assets, other extraordinary gains or losses, and any
one
-time adjustment approved by the lender.
  At
September 30, 2017,
the Company was in compliance with its loan covenant requirements.
               
 
The Company anticipates it will be able to refinance its term loan and renew its revolving line of credit with its current lender prior to the respective maturity dates of each agreement; however, there can be
no
assurance that the Company will be successful in refinancing its outstanding loan balances prior to maturity.
  Company management believes that the Company's cash on hand and its ability, if necessary, to borrow a significant portion of or liquidate the cash surrender value of the Company's key-man life insurance policy, will be sufficient to meet the Company's working capital requirements and debt service requirements for the next
twelve
months.